TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 47 filers reported holding TAYSHA GENE THERAPIES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,507,851 | +10106.8% | 24,527,801 | +2035.0% | 0.01% | – |
| Q2 2023 | $759,374 | -84.6% | 1,148,827 | -81.4% | 0.00% | – |
| Q1 2023 | $4,924,922 | -32.0% | 6,174,676 | +92.7% | 0.00% | -100.0% |
| Q4 2022 | $7,243,124 | +14.2% | 3,204,922 | -2.5% | 0.00% | 0.0% |
| Q3 2022 | $6,342,000 | -48.3% | 3,285,783 | -0.3% | 0.00% | 0.0% |
| Q2 2022 | $12,260,000 | -42.9% | 3,295,689 | +0.0% | 0.00% | -50.0% |
| Q1 2022 | $21,483,000 | -56.9% | 3,294,821 | -23.0% | 0.00% | -50.0% |
| Q4 2021 | $49,868,000 | -53.5% | 4,280,494 | -25.7% | 0.00% | -55.6% |
| Q3 2021 | $107,226,000 | -11.1% | 5,758,674 | +1.2% | 0.01% | 0.0% |
| Q2 2021 | $120,577,000 | +4.9% | 5,687,616 | +0.4% | 0.01% | -10.0% |
| Q1 2021 | $114,984,000 | -22.2% | 5,664,215 | 0.0% | 0.01% | -23.1% |
| Q4 2020 | $147,862,000 | +64.1% | 5,664,215 | +34.6% | 0.01% | +44.4% |
| Q3 2020 | $90,087,000 | – | 4,207,574 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 1,391,190 | $29,493,000 | 22.62% |
| Octagon Capital Advisors LP | 320,440 | $6,793,000 | 1.41% |
| Artal Group S.A. | 1,040,882 | $22,067,000 | 0.45% |
| Alphabet Inc. | 640,882 | $13,587,000 | 0.28% |
| Nantahala Capital Management | 432,072 | $9,160,000 | 0.26% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $10,600,000 | 0.22% |
| TimesSquare Capital Management, LLC | 683,400 | $14,488,000 | 0.12% |
| Perceptive Advisors | 640,880 | $13,586,000 | 0.09% |
| Virtus ETF Advisers LLC | 8,697 | $184,000 | 0.08% |
| Granite Point Capital Management, L.P. | 50,000 | $1,060,000 | 0.04% |